A recent study of the Sysmex XR-20 in Belgium found that it's performance was acceptable according to EFLM and Ricos criteria. But what if the instrument was held to the CLIA 2025 standard?
A recent study of the ADVIA 2120i hematology analyzer in Vietnam used the 2014 Ricos goals to assess quality. What if the CLIA 2025 goals were applied instead?
A recent study looked at the analytical performance of a Erba XL 640 in Kolkata, India. A trend of poor performance is starting to emerge with the Erba analyzers. Is it the instrument? Or is it where the instruments are operated?
There's a new analyzer for hematology, the Atellica HEMA 580. A recent study looked at the its analytical performance in South Korea. Can the new analyzer meet the new CLIA 2025 goals?
A recent study looked at the analytical performance of a Roche cobas c301 in Dubai. Unfortunately, a few mistakes were made in the published version of the calculations. We correct them here.